Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems


Bristol’s Yervoy falls short in prostate cancer study

Bristol-Myers Squibb Co’s immunotherapy drug Yervoy failed to significantly prolong survival among patients with advanced prostate cancer who had previously received chemotherapy, according to limited data from the first late-stage study of the drug for the condition.

Yervoy (ipilimumab) frees the immune system to attack and kill cancer cells by blocking the action of… Bristol’s Yervoy falls short in prostate cancer study   

psa21 - obesity5 - bladder symptoms1 - green k1 - kidney disorder1 - symptomatic stone event1 - ontario health insurance plan1 - genetic disorders1 - retrograde ureteropyelogram1 - interstitial cystitis2 - uterine fibroid embolization1 - ultrasonography1 - embryogenesis1 - distal tubule1 - iga nephropathy2 - wastage syndrome1 - lab-made kidney1 - urinary stones6 - cyclophosphamide1 - fsgs2 - diabetic kidney1 - adhd1 - psa velocity1 - microhematuria1 - tumor metabolism1 - desire or erection1 - prostate cancer imaging1 - jcem1 - urinary drainage1 - nephrons2 -